CXCL10 and neopterin in CSF are candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis

Ítems similars

• CSF CXCL10, CXCL9, and Neopterin as Candidate Prognostic Biomarkers for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
  per: Sato, Tomoo, et al.
  Publicat: (2013)
• Cerebrospinal Fluid CXCL10 as a Candidate Surrogate Marker for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
  per: Tamaki, Keiko, et al.
  Publicat: (2019)
• Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan
  per: Shuntaro Tsutsumi, et al.
  Publicat: (2019-10-01)
• Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan
  per: Tsutsumi, Shuntaro, et al.
  Publicat: (2019)
• Nation-wide epidemiological study in Japan on HTLV-1 associated myelopathy/tropical spastic paraparesis using HAM-net, a novel patient registration system
  per: Coler-Reilly, Ariella LG, et al.
  Publicat: (2014)